Latest Insulet News & Updates

See the latest news and media coverage for Insulet. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Insulet

Maker of tubeless insulin delivery systems

insulet.com
Headquarters
Acton, United States
Founded year
2000
Company type
Public company
Number of employees
1,000–5,500

Last updated

Latest news about Insulet

In short: Insulet expanded the Omnipod 5 market presence and initiated a pivotal type 2 diabetes study while managing a voluntary medical device correction.

Company announcements

  • Insulet

    Insulet reports Q1 2026 results

    Revenue reaches $761.7M, up 33.9%; raises full-year guidance. Launches Omnipod 5 in Middle East, updates algorithm.

  • Insulet

    Insulet enrolls first participant in EVOLVE study

    The pivotal trial tests a fully closed-loop automated insulin delivery system for type 2 diabetes, aiming for FDA submission in 2027.

  • Insulet

    Insulet advances diabetes technology innovations

    It launches data platform, updates Omnipod 5 algorithm, and develops Omnipod 6 and type 2 closed-loop system.

  • Insulet

    Insulet appoints Mike Panos as Chief Commercial Officer

    He will lead the global commercial organization, reporting to CEO Ashley McEvoy. Panos brings 30 years of experience from Stryker.

Unlock all announcements with a

Media coverage

  • The Globe and Mail

    Insulet Earnings Call Highlights Growth, Guidance Upgrade

    Insulet’s latest earnings call carried an upbeat tone, with management emphasizing powerful revenue growth, expanding margins, and a fast-advancing product pipeline. While executives acknowledged ...

  • Reuters

    Insulet lifts annual revenue forecast after quarterly beat on strong insulin pump demand

    Insulet raised its annual revenue growth forecast on Wednesday after reporting better-than-expected quarterly results, ​driven by strong demand for its tubeless ‌insulin pumps that eliminate...

  • WTOP

    Insulet: Q1 Earnings Snapshot

    Insulet Corp. (PODD) on Wednesday reported first-quarter profit of $91.1 million. The Acton, Massachusetts-based company said it had profit of $1.30 per share.

  • Morningstar

    Insulet Initiates EVOLVE Pivotal Study to Advance Fully Closed-Loop Automated...

    Insulet Initiates EVOLVE Pivotal Study to Advance Fully Closed-Loop Automated Insulin Delivery System for Type 2 Diabetes First participant enrolled in randomized control trial designed...

Unlock all articles with a

Never miss news about Insulet

Track Insulet and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Insulet competitors & trending companies

Browse news for competitors to Insulet and other trending companies.